According to Lipella Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.65. In 2022 the company made an earnings per share (EPS) of -$0.45 a decrease over its 2021 EPS that were of -$0.32.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.65 | 43.2% |
2022 | -$0.45 | 39.25% |
2021 | -$0.32 |